CSL
Driven by our promise to help patients lead full lives. Social Guidelines: https://bit.ly/3Bs17Ra
Rare Disease Day is coming up next week, so we asked the leaders of patient advocacy groups – and CSL staff – to explain why rare conditions deserve attention and recognition as a global health concern.
Read more about their reasons for action: https://bit.ly/3wp0YPk
Small acts of kindness can have a big impact. Share your acts of kindness and inspire others to join in. Let's make the world a better place, one random act of kindness at a time.
Love is best when it’s shared. Wishing everyone a Happy Valentine’s Day.
CEO and Managing Director Paul McKenzie speaks to the outlook for CSL. A recording of our half year earnings webcast can be found at our investor center: https://bit.ly/4bEgcQr
CSL's CEO and Managing Director Paul McKenzie summarizes our financial performance for the first half of FY2024. More: https://bit.ly/3wfn4nc
We have just released our half year results for financial year 2024. Check out a snapshot below, or head to our investor center for more information. https://bit.ly/3utomKV
Today, we announced top-line results from the Phase 3 AEGIS-II trial. Read more: https://bit.ly/3SDRvuY
Global Newsroom | CSL Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
At CSL, we are leading the way in addressing serious and rare diseases. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory and transplant therapeutic areas. Learn more: https://bit.ly/3SvlxRw
At CSL, our patients are our passion and this drives the way we work. We proudly celebrate National Patient Recognition Week and are committed to supporting patients all through the year.
Today is American Heart Association’s National . We’re proud to show our support and continue to educate others on the risks of heart disease. Get involved at: https://bit.ly/3ulZDYT Go Red for Women
February is American , and CSL is determined to do our part in the fight against . We strive to pave the way for a better future for CV patients worldwide through our and metabolic research program.
What are the leaders of patient advocacy groups planning for 2024? We checked in with leaders who represent patients who live with CIDP, immune deficiencies, bleeding disorders and other rare and serious conditions. Find out what they're planning to accomplish ..
Patient Advocacy Groups Share 2024 Plans Answering CSL.com’s survey, the leaders of nonprofit patient organizations said they are looking forward to a productive year representing people who live with rare and serious diseases.
Join us in celebrating International Day of Education on January 24th, an observance established by the UN to acknowledge the crucial role of inclusive, equitable, and quality education in fostering peace and sustainable development.
At CSL, we believe in the power of education to transform lives and create Promising Futures. Through our investment in a variety of learning programs and training and development tools, we provide the resources and support our people need to do meaningful work and grow professionally. This , let's embrace the significance of lifelong learning opportunities for everyone.
The Headspace app is your personal guide to stress less, increase focus, improve sleep, and introduce mindfulness and meditation into your daily life. CSL pays 100% of the subscription for you and your loved one.
Learn more: https://bit.ly/48H0CBR
CSL is excited to announce “Wellness Days" are now a permanent benefit for CSL employees worldwide. This is extra time off – separate from Paid Time Off – that our colleagues can use for medical appointments, spending time with family or to recharge and regroup. CSL is committed to prioritizing our people and their wellbeing because they – and the work they do every day – are vital to our ability to deliver on our promise.
Join a team that cares https://bit.ly/3O8yuiW
As a company committed to offering a diverse and inclusive work environment, we are proud to announce that CSL is recognized as one of America’s Greatest Workplaces for Diversity 2024 by Newsweek and Plant-A Insights Group. This survey of over 220,000 individuals included representation at over 1.5 million companies in America. Read more https://bit.ly/3Smvy4v
Join a team that fosters a diverse and inclusive culture.
In this video, Eke and Sterre talk about life with hemophilia, a bleeding disorder mostly associated with men. They’re advocating for more awareness and better care for the symptoms women experience.
Read more: https://bit.ly/3RYGrIt
CSL is committed to listening to and understanding the concerns of people living with . We recently partnered with The Harris Poll on a survey to gain insights into opinions and perceptions of treatments among people living with CIDP and neurologists/neuromuscular specialists. Read more here: https://bit.ly/3So45zG
Today, we honor and reflect on the profound legacy of Dr. Martin Luther King Jr. Let us commit to advancing his dream of equality, justice and peace by promoting compassion and understanding every day.
At CSL, we put patients first and deliver on our promise to save lives. Together, we're making a difference every day.
Take a behind-the-scenes look at Danzi Song, R&D Scientist at CSL, putting together lifesaving solutions and revolutionizing the way R&D works.
https://bit.ly/3RPG82B
A beautiful summer morning dawns with the sun shining on CSL’s Global Headquarters and Centre for R&D, which stands proudly as a landmark on the Melbourne skyline, and in the heart of the biomedical district.
📷: /Instagram
Exciting news! CSL was named one of the 2024 Best Places to Work by BioSpace. BioSpace assesses key employer values like culture, leadership, innovation, and career growth and development when considering winners.
Congratulations to our employees for making CSL an outstanding place to work. Join our team and do work that matters: https://bit.ly/48LM2bL
If you're a member of a patient community, you'll want to hear what leaders of advocacy organizations have planned for 2024. https://bit.ly/47mi8dg Immune Deficiency Foundation World Federation of Hemophilia Hereditary Angioedema Association - HAEA Alpha-1 Foundation GBS-CIDP Foundation International IPOPI Fundación Lovexair
Patient Advocacy Groups Share 2024 Plans Answering CSL.com’s survey, the leaders of nonprofit patient organizations said they are looking forward to a productive year representing people who live with rare and serious diseases.
At CSL, we remain committed to listening to and understanding the concerns of people living with rare diseases, such as Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Check out our latest advancement to help meet the needs of individuals living with or here: https://bit.ly/3H69CUY
Click here to claim your Sponsored Listing.
Driven By Our Promise
It began with a promise. CSL Behring's parent company, CSL, was formed more than 100 years ago to save lives using the latest technologies. In the century since, CSL Behring has grown into a global biotechnology leader, driven by that same promise to save and improve lives. We offer the broadest range of quality plasma-derived and recombinant therapies in our industry. Our ability to innovate and deliver life-saving medicines for patients with rare disease and other unmet medical needs around the world has earned us a reputation for always putting patients first. We are CSL Behring and we are driven by our promise.
Videos (show all)
Category
Telephone
Website
Address
645 Elizabeth Street
Melbourne, VIC
3000
Suite 075 Waterman Business Centre 44 Lakeview Drive
Melbourne, 3179
We partner with innovative companies in industry, environment, and agriculture to provide safe & su
84 Hotham Street, Preston
Melbourne, 3072
Arovella Therapeutics is a biotechnology company focused on developing its unique iNKT cell therapy platform to treat cancer.
13
Melbourne, 3016
CASSA BioTec is a biotechnology company that harnesses nature’s own processes such as active enzymes and beneficial bacteria to create commercial solutions for the sanitation, agri...
Level 35/600 Bourke Street
Melbourne, 3000
ZivBio hopes to provide a more environmentally friendly option for businesses and consumers that still wish to use single-use products by offering products that will biodegrade and...
24 Cromwell Street
Melbourne, 3066
ZiP Diagnostics is an Australian owned, Melbourne based biotech company that has developed simple, economical solutions for infectious disease diagnostics. ZiP has its Melbourne he...
Melbourne
Australian made long-lasting surface coating developed with natural ingredients and latest antimicrobial technology.
7 Leader Street
Melbourne, 3061
We engaged in the research and development, manufacture and sales of intelligent biotech solutions.
Level 1, 95 Albert Street
Melbourne, 3056
We use environmental DNA (eDNA) to help professionals more efficiently detect and monitor wildlife.
439 St Georges Road
Melbourne, 3071
Fungi Solutions collaborates with Fungi to rescue resources from landfill, produce sustainable circular packaging solutions and remediate toxic pollutants.
Melbourne
We are leading a next-generation lung delivery system to protect every child from infections.
Melbourne, VIC3153
VanEyk Pty Ltd, based in Victoria Australia, has been supplying specialised chemical products to Australian Industry since 1994. We specialise in products that revolve around the c...